- RecruitingPHASE1, PHASE2
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
This study looks at new drug combinations for multiple myeloma that has come back or isn't responding to usual treatment. It checks how safe they are, body reactions, and early signs of how well they might work.
For: Multiple MyelomaUnited States · Canada · Norway - Active not recruitingPHASE1, PHASE2
A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
This study looks at a new drug, BMS-986158, alone or with other medicines like Ruxolitinib or Fedratinib, for a type of blood cancer called myelofibrosis. Researchers want to see if these treatments are safe and how well they work.
For: MyelofibrosisUnited States · Australia · France